首页 > 最新文献

Israel journal of medical sciences最新文献

英文 中文
The use of DNA markers in the pre-clinical diagnosis of familial adenomatous polyposis. DNA标记在家族性腺瘤性息肉病临床前诊断中的应用。
Pub Date : 1997-01-01
D Amikam, D Niv, J Lachter, S Eidelman, Z Ben-Ishai

Familial adenomatous polyposis (FAP), an autosomal dominant inherited disease, confers a high risk of colon cancer. For presymptomatic diagnosis of FAP, we performed linkage studies in three unrelated Israeli families with FAP, using seven polymorphic systems around or at the APC locus on chromosome 5q. These systems are constituted of three DNA probes, recognizing four restriction fragment length polymorphism: C11p11, YN5.48 and pi227; three cytosine-adenine repeat markers: D5S318, D5S346 and MBC; and one intragenic polymorphism: APC-SspI. A meiotic recombination event was detected, apparently between the FAP gene and probe pi227. Based on the different analysis systems, we determined the haplotype at the APC locus in 11 at-risk individuals of the three families, six of whom were found to carry the disease-linked allele. Additionally, we identified a new FAP patient, in whom sigmoidoscopy showed the presence of adenomatous polyps throughout the colon.

家族性腺瘤性息肉病(FAP)是一种常染色体显性遗传病,具有结肠癌的高风险。为了进行FAP的症状前诊断,我们在三个不相关的以色列FAP家族中进行了连锁研究,使用了染色体5q上APC位点周围或附近的7个多态系统。该系统由三个DNA探针组成,识别四种限制性片段长度多态性:C11p11、YN5.48和pi227;3个胞嘧啶-腺嘌呤重复标记:D5S318、D5S346和MBC;一个基因内多态性:APC-SspI。在FAP基因和探针pi227之间检测到减数分裂重组事件。基于不同的分析系统,我们确定了3个家族中11个高危个体APC位点的单倍型,其中6个被发现携带疾病相关等位基因。此外,我们发现了一个新的FAP患者,乙状结肠镜检查显示整个结肠存在腺瘤性息肉。
{"title":"The use of DNA markers in the pre-clinical diagnosis of familial adenomatous polyposis.","authors":"D Amikam,&nbsp;D Niv,&nbsp;J Lachter,&nbsp;S Eidelman,&nbsp;Z Ben-Ishai","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Familial adenomatous polyposis (FAP), an autosomal dominant inherited disease, confers a high risk of colon cancer. For presymptomatic diagnosis of FAP, we performed linkage studies in three unrelated Israeli families with FAP, using seven polymorphic systems around or at the APC locus on chromosome 5q. These systems are constituted of three DNA probes, recognizing four restriction fragment length polymorphism: C11p11, YN5.48 and pi227; three cytosine-adenine repeat markers: D5S318, D5S346 and MBC; and one intragenic polymorphism: APC-SspI. A meiotic recombination event was detected, apparently between the FAP gene and probe pi227. Based on the different analysis systems, we determined the haplotype at the APC locus in 11 at-risk individuals of the three families, six of whom were found to carry the disease-linked allele. Additionally, we identified a new FAP patient, in whom sigmoidoscopy showed the presence of adenomatous polyps throughout the colon.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"8-13"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute myocardial infarction after extracorporeal shock-wave lithotripsy: a dilemma of management. 体外冲击波碎石后急性心肌梗死:处理的困境。
Pub Date : 1997-01-01
M Perouansky, R Pizov
{"title":"Acute myocardial infarction after extracorporeal shock-wave lithotripsy: a dilemma of management.","authors":"M Perouansky,&nbsp;R Pizov","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"71-4"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of domiciliary long-term oxygen therapy with oxygen concentrators. 家用吸氧器长期氧疗效果评价。
Pub Date : 1997-01-01
R J Shiner, U Zaretsky, M Mirali, S Benzaray, D Elad

Domiciliary long-term oxygen therapy (LTOT) is usually supplied by means of oxygen concentrators (OCs). Various factors that determine the efficacy of such a treatment were evaluated. Sixty-three patients, arbitrarily selected from lists of health care providers, were visited at home by a biomedical engineer and a pulmonary function technician. The evaluation consisted of: i) responses to a directed questionnaire, ii) assessment of the OC output characteristics, and iii) measurement of the patient's oxygen saturation (SaO2) at rest with and without oxygen supplement. Only 33% of patients received oxygen treatment for the recommended 12-24 hours/day and 5% of patients waited the recommended 10 minutes of OC warm-up before connection. Filters were cleaned weekly by only 30% of patients and the concentrator was serviced 3-4 times a year in 25% of cases. The OC was thought to be unduly noisy by 24% of patients and connecting tubing of less than 6 meters was fitted to 90% of OCs, thereby limiting patient mobility. Most of the OCs did not yield the recommended oxygen concentration and the flow rate meters on them tended to underread. Therefore, only 22% of patients received the prescribed oxygen supplement. Whilst breathing room air, a substantial proportion of patients had an SaO2 >90%. Improvements are clearly required in terms of medical indications for LTOT, patient education and supervision, supply and maintenance of concentrators and related equipment.

居家长期氧疗(LTOT)通常由氧浓缩器(OCs)提供。评估了决定这种治疗效果的各种因素。一名生物医学工程师和一名肺功能技术员到63名患者家中进行了拜访,这些患者是从医疗保健提供者名单中任意挑选出来的。评估包括:i)直接问卷的回答,ii)评估OC输出特征,以及iii)测量患者在休息时的氧饱和度(SaO2),有无补充氧气。只有33%的患者接受了推荐的12-24小时/天的氧气治疗,5%的患者在连接前等待了推荐的10分钟的OC预热。只有30%的患者每周清洗过滤器,25%的患者每年使用浓缩器3-4次。24%的患者认为OC噪音过大,90%的OC安装了小于6米的连接管,从而限制了患者的活动能力。大多数OCs不能产生推荐的氧浓度,其上的流速计往往读数不足。因此,只有22%的患者接受了规定的氧气补充。当呼吸室内空气时,相当比例的患者SaO2 >90%。在lot的医学指征、患者教育和监督、浓缩器和相关设备的供应和维护等方面显然需要改进。
{"title":"Evaluation of domiciliary long-term oxygen therapy with oxygen concentrators.","authors":"R J Shiner,&nbsp;U Zaretsky,&nbsp;M Mirali,&nbsp;S Benzaray,&nbsp;D Elad","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Domiciliary long-term oxygen therapy (LTOT) is usually supplied by means of oxygen concentrators (OCs). Various factors that determine the efficacy of such a treatment were evaluated. Sixty-three patients, arbitrarily selected from lists of health care providers, were visited at home by a biomedical engineer and a pulmonary function technician. The evaluation consisted of: i) responses to a directed questionnaire, ii) assessment of the OC output characteristics, and iii) measurement of the patient's oxygen saturation (SaO2) at rest with and without oxygen supplement. Only 33% of patients received oxygen treatment for the recommended 12-24 hours/day and 5% of patients waited the recommended 10 minutes of OC warm-up before connection. Filters were cleaned weekly by only 30% of patients and the concentrator was serviced 3-4 times a year in 25% of cases. The OC was thought to be unduly noisy by 24% of patients and connecting tubing of less than 6 meters was fitted to 90% of OCs, thereby limiting patient mobility. Most of the OCs did not yield the recommended oxygen concentration and the flow rate meters on them tended to underread. Therefore, only 22% of patients received the prescribed oxygen supplement. Whilst breathing room air, a substantial proportion of patients had an SaO2 >90%. Improvements are clearly required in terms of medical indications for LTOT, patient education and supervision, supply and maintenance of concentrators and related equipment.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"23-9"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel. 提出低剂量r-HuEPO每周一次皮下注射治疗透析前慢性肾功能衰竭患者贫血的治疗算法。多中心研究组,以色列。
Pub Date : 1997-01-01
Y Yagil

Anemia of chronic renal failure (CRF) prior to initiation of dialysis is an important cause of morbidity and requires early therapeutic intervention. The current study was designed to investigate the efficacy and tolerability of a therapeutic algorithm for anemia of CRF in pre-dialysis patients which is based on low dose once-a-week subcutaneous (s.c.) administration of recombinant human erythropoietin (r-HuEPO). Thirty-one patients participated in a prospective open-label multicenter study. At baseline, hemoglobin was 8.8+/-0.1 g/dl, transferrin saturation 27+/-2%, ferritin 207+/-28 ng/ml and serum creatinine 4.7+/-0.2 mg/dl. Treatment with r-HuEPO was started at a fixed s.c. dose of 4,000 units once weekly, irrespective of body weight, and titrated upwards or downwards according to a predetermined algorithm. Hemoglobin rose to levels >10 g/dl within 8 weeks and remained stable throughout the remaining period of the study. By week 24, most patients required

慢性肾功能衰竭(CRF)开始透析前的贫血是发病率的重要原因,需要早期治疗干预。目前的研究旨在探讨透析前患者CRF贫血的治疗方法的疗效和耐受性,该方法基于每周一次的低剂量皮下给药重组人促红细胞生成素(r-HuEPO)。31名患者参加了一项前瞻性开放标签多中心研究。基线时,血红蛋白为8.8+/-0.1 g/dl,转铁蛋白饱和度为27+/-2%,铁蛋白为207+/-28 ng/ml,血清肌酐为4.7+/-0.2 mg/dl。r-HuEPO治疗开始时的剂量为固定的s.c.,每周一次,剂量为4,000单位,与体重无关,并根据预先确定的算法向上或向下滴定。血红蛋白在8周内上升到>10 g/dl的水平,并在研究的剩余期间保持稳定。到第24周,大多数患者需要
{"title":"Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.","authors":"Y Yagil","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Anemia of chronic renal failure (CRF) prior to initiation of dialysis is an important cause of morbidity and requires early therapeutic intervention. The current study was designed to investigate the efficacy and tolerability of a therapeutic algorithm for anemia of CRF in pre-dialysis patients which is based on low dose once-a-week subcutaneous (s.c.) administration of recombinant human erythropoietin (r-HuEPO). Thirty-one patients participated in a prospective open-label multicenter study. At baseline, hemoglobin was 8.8+/-0.1 g/dl, transferrin saturation 27+/-2%, ferritin 207+/-28 ng/ml and serum creatinine 4.7+/-0.2 mg/dl. Treatment with r-HuEPO was started at a fixed s.c. dose of 4,000 units once weekly, irrespective of body weight, and titrated upwards or downwards according to a predetermined algorithm. Hemoglobin rose to levels >10 g/dl within 8 weeks and remained stable throughout the remaining period of the study. By week 24, most patients required <or =4,000 units/week as maintenance dose. Transferrin saturation and ferritin concentration tended to fall during the course of r-HuEPO treatment, despite iron supplementation. There was no change in white blood cell or platelet count. Eight patients required an increase in antihypertensive therapy, but blood pressure remained well-controlled. Twelve patients failed to complete the full length of the study, 7 of them because dialysis had to be initiated. The rate of decline in kidney function, however, was not altered by r-HuEPO. We conclude that the proposed therapeutic algorithm is practical, efficacious, safe, and cost-effective.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"36-44"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Home monitoring for infants at high risk for the sudden infant death syndrome. 婴儿猝死综合征高危人群的家庭监测
Pub Date : 1997-01-01
Y Sivan, A Kornecki, A Baharav, N Glaser, Z Spirer

The rate of sudden infant death syndrome (SIDS) In Israel is relatively low (0.5-0.9:1,000). Home cardiorespiratory monitoring (HM) is an accepted practice in infants at high risk for SIDS. We report our experience with 261 infants who were referred to our SIDS prevention program. They included: 52 preterm infants with apneas and bradycardias, 83 SIDS siblings (3 twins), 22 infants of drug-addicted mothers, and 104 infants after an idiopathic apparent life-threatening event (ALTE). HM was performed in 40 of 52 preterms, 38 of 83 SIDS siblings, all 22 infants of addicted mothers and 67 of 104 post-ALTE. All received 24 h/day medical and technical backup as well as emotional support, and were closely followed until 15 months of age. None of the 261 infants died. Five infants experienced six ALTEs that required resuscitative measures; another 28 infants had monitor alarms judged as real by the caregivers. The average duration of HM was 3.2 months (range 1-7). In 8 of 167 cases the parents stopped HM earlier than recommended, and in 34 of 167 cases (20%), parents continued HM beyond the time when discontinuation was recommended by the medical personnel. Among the caregivers, 85% found HM to be reassuring and stated that it helped them to conduct a normal life. We suggest that in our population, HM may have a favorable effect on family life. With close backup and support, most families will benefit from HM and will gain reassurance that will enable them to conduct normal life.

以色列婴儿猝死综合症(SIDS)的发病率相对较低(0.5-0.9:1 000)。家庭心肺监测(HM)是SIDS高风险婴儿的一种公认做法。我们报告了261名被转介到我们的小岛屿发展中国家预防项目的婴儿的经验。他们包括:52名患有呼吸暂停和心动过缓的早产儿,83名SIDS兄弟姐妹(3对双胞胎),22名母亲吸毒成瘾的婴儿,以及104名特发性明显危及生命事件(ALTE)后的婴儿。对52名早产儿中的40名,83名SIDS兄弟姐妹中的38名,所有22名成瘾母亲的婴儿和104名alte后的67名进行了HM。所有人都得到了24小时的医疗和技术支持以及情感支持,并被密切跟踪直到15个月大。261名婴儿无一死亡。5名婴儿经历了6次alte,需要采取复苏措施;另外28名婴儿的监视器警报被看护人判断为真实的。HM的平均持续时间为3.2个月(范围1 ~ 7个月)。167例中有8例家长比建议更早停止母乳喂养,167例中有34例(20%)家长继续母乳喂养超过了医务人员建议停止母乳喂养的时间。在护理人员中,85%的人认为HM令人放心,并表示它帮助他们过上了正常的生活。我们认为,在我们的人群中,HM可能对家庭生活有有利的影响。有了密切的支持和支持,大多数家庭将受益于HM,并将获得保证,使他们能够过正常的生活。
{"title":"Home monitoring for infants at high risk for the sudden infant death syndrome.","authors":"Y Sivan,&nbsp;A Kornecki,&nbsp;A Baharav,&nbsp;N Glaser,&nbsp;Z Spirer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The rate of sudden infant death syndrome (SIDS) In Israel is relatively low (0.5-0.9:1,000). Home cardiorespiratory monitoring (HM) is an accepted practice in infants at high risk for SIDS. We report our experience with 261 infants who were referred to our SIDS prevention program. They included: 52 preterm infants with apneas and bradycardias, 83 SIDS siblings (3 twins), 22 infants of drug-addicted mothers, and 104 infants after an idiopathic apparent life-threatening event (ALTE). HM was performed in 40 of 52 preterms, 38 of 83 SIDS siblings, all 22 infants of addicted mothers and 67 of 104 post-ALTE. All received 24 h/day medical and technical backup as well as emotional support, and were closely followed until 15 months of age. None of the 261 infants died. Five infants experienced six ALTEs that required resuscitative measures; another 28 infants had monitor alarms judged as real by the caregivers. The average duration of HM was 3.2 months (range 1-7). In 8 of 167 cases the parents stopped HM earlier than recommended, and in 34 of 167 cases (20%), parents continued HM beyond the time when discontinuation was recommended by the medical personnel. Among the caregivers, 85% found HM to be reassuring and stated that it helped them to conduct a normal life. We suggest that in our population, HM may have a favorable effect on family life. With close backup and support, most families will benefit from HM and will gain reassurance that will enable them to conduct normal life.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"45-9"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac contractility: modulation of myofibrillar calcium sensitivity by beta-adrenergic stimulation. 心脏收缩力:β -肾上腺素能刺激对肌原纤维钙敏感性的调节。
Pub Date : 1997-01-01
H Kögler, J C Rüegg

Under conditions of beta-adrenergic receptor stimulation, cardiac performance is enhanced. cAMP-dependent phosphorylation of proteins located in the sarcolemma, in the membrane of the sarcoplasmic reticulum (SR), and in the myofibrils of the cardiomyocytes, mediates the effects of catecholamines on the heart. Altered Ca2+ handling leads to increased levels of intracellular free Ca2+. This is mainly responsible for the enhanced contractility of the myocardium that can be observed following beta-adrenergic receptor stimulation. Phosphorylation of the thin filament regulatory protein troponin I (TnI), on the other hand, decreases the Ca2+ sensitivity of the myofilaments, which means that the Ca2+ concentration necessary for the development of half-maximal force is increased. Cardiac TnI has a 26-33 amino acid N-terminal extension that is not present in fast and slow skeletal muscle TnI isoforms. Within this segment, two adjacent serine residues can be phosphorylated by a cAMP-dependent protein kinase. Replacement of endogenous TnI by different mutants obtained using site-directed mutagenesis of one or both of the serine residues has shown that only the bis-phosphorylated form decreases the Ca2+ sensitivity. This Ca2+ desensitizing effect, together with an increased rate of Ca2+ uptake into the SR due to phosphorylation of the SR membrane protein phospholamban, is responsible for the relaxation-enhancing effect (lusitropic action) of catecholamines. The latter is an important determinant of coronary perfusion and rapid diastolic filling of the ventricles, and is also a prerequisite for the elevation of heart rate that accompanies beta-adrenergic receptor stimulation.

在β -肾上腺素能受体刺激的条件下,心脏功能增强。位于肌膜、肌浆网(SR)膜和心肌细胞肌原纤维中的camp依赖性蛋白磷酸化可介导儿茶酚胺对心脏的作用。改变Ca2+处理导致细胞内游离Ca2+水平增加。这是β -肾上腺素能受体刺激后心肌收缩力增强的主要原因。另一方面,细丝调节蛋白肌钙蛋白I (TnI)的磷酸化降低了肌丝的Ca2+敏感性,这意味着发展半最大力所需的Ca2+浓度增加。心脏TnI具有26-33个氨基酸n端延伸,这在快速和缓慢的骨骼肌TnI亚型中不存在。在这个片段中,两个相邻的丝氨酸残基可以被camp依赖性蛋白激酶磷酸化。通过一个或两个丝氨酸残基的定点诱变获得的不同突变体替代内源性TnI,表明只有双磷酸化形式会降低Ca2+敏感性。这种Ca2+脱敏效应,加上由于SR膜蛋白磷蛋白的磷酸化而增加的Ca2+摄取率,是儿茶酚胺松弛增强作用(lusitorenaction)的原因。后者是冠状动脉灌注和心室快速舒张充盈的重要决定因素,也是伴随β -肾上腺素能受体刺激的心率升高的先决条件。
{"title":"Cardiac contractility: modulation of myofibrillar calcium sensitivity by beta-adrenergic stimulation.","authors":"H Kögler,&nbsp;J C Rüegg","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Under conditions of beta-adrenergic receptor stimulation, cardiac performance is enhanced. cAMP-dependent phosphorylation of proteins located in the sarcolemma, in the membrane of the sarcoplasmic reticulum (SR), and in the myofibrils of the cardiomyocytes, mediates the effects of catecholamines on the heart. Altered Ca2+ handling leads to increased levels of intracellular free Ca2+. This is mainly responsible for the enhanced contractility of the myocardium that can be observed following beta-adrenergic receptor stimulation. Phosphorylation of the thin filament regulatory protein troponin I (TnI), on the other hand, decreases the Ca2+ sensitivity of the myofilaments, which means that the Ca2+ concentration necessary for the development of half-maximal force is increased. Cardiac TnI has a 26-33 amino acid N-terminal extension that is not present in fast and slow skeletal muscle TnI isoforms. Within this segment, two adjacent serine residues can be phosphorylated by a cAMP-dependent protein kinase. Replacement of endogenous TnI by different mutants obtained using site-directed mutagenesis of one or both of the serine residues has shown that only the bis-phosphorylated form decreases the Ca2+ sensitivity. This Ca2+ desensitizing effect, together with an increased rate of Ca2+ uptake into the SR due to phosphorylation of the SR membrane protein phospholamban, is responsible for the relaxation-enhancing effect (lusitropic action) of catecholamines. The latter is an important determinant of coronary perfusion and rapid diastolic filling of the ventricles, and is also a prerequisite for the elevation of heart rate that accompanies beta-adrenergic receptor stimulation.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The fight against AIDS. 抗击艾滋病的斗争。
Pub Date : 1997-01-01
E Shafrir
{"title":"The fight against AIDS.","authors":"E Shafrir","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"80"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20157670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pituitary mass and hypopituitarism: improvement after corticosteroid therapy. 垂体肿块和垂体功能减退:皮质类固醇治疗后的改善。
Pub Date : 1997-01-01
I Shimon, M Berezin, M Hadani, R Tadmor, D Gross, A Karasik

Lymphocytic hypophysitis of the anterior pituitary is a rare autoimmune disease, invariably diagnosed either by surgical biopsy of the adenohypophysis or at autopsy. The current report describes the rapid development of hypopituitarism in a 42-year-old nulliparous woman with a large sellar mass, who did not undergo pituitary surgery. Transient regression of the sellar mass and partial improvement of the hypopituitarism was induced by treatment with corticoids. We suggest that the diagnosis of lymphocytic hypophysitis can be established clinically and that conservative treatment with corticoids should be considered prior to surgical intervention.

垂体前叶淋巴细胞性垂体炎是一种罕见的自身免疫性疾病,通常通过腺垂体手术活检或尸检诊断。目前的报告描述了一个42岁的未生育妇女垂体功能减退症的快速发展与大鞍块,谁没有接受垂体手术。经皮质激素治疗后鞍块短暂消退,垂体功能减退部分改善。我们建议淋巴细胞性垂体炎的诊断可以在临床上确定,在手术干预之前应考虑使用皮质激素进行保守治疗。
{"title":"A pituitary mass and hypopituitarism: improvement after corticosteroid therapy.","authors":"I Shimon,&nbsp;M Berezin,&nbsp;M Hadani,&nbsp;R Tadmor,&nbsp;D Gross,&nbsp;A Karasik","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lymphocytic hypophysitis of the anterior pituitary is a rare autoimmune disease, invariably diagnosed either by surgical biopsy of the adenohypophysis or at autopsy. The current report describes the rapid development of hypopituitarism in a 42-year-old nulliparous woman with a large sellar mass, who did not undergo pituitary surgery. Transient regression of the sellar mass and partial improvement of the hypopituitarism was induced by treatment with corticoids. We suggest that the diagnosis of lymphocytic hypophysitis can be established clinically and that conservative treatment with corticoids should be considered prior to surgical intervention.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"58-62"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of oleic acid lung injury and positive end-expiratory pressure on central hemodynamics and regional blood flow. 油酸肺损伤和呼气末正压对中央血流动力学和局部血流的影响。
Pub Date : 1997-01-01
S Walfisch, N Weksler, A Fisher, Y Shapira

The objective of our study was to investigate the influence on central and regional circulation of the application of positive end-expiratory pressure (PEEP=P) in a canine model of low hydrostatic pulmonary edema. Eight mongrel dogs with oleic acid-induced pulmonary edema were artificially ventilated with and without PEEP. Regional blood flow was determined using radioactive microspheres directly injected into the left ventricle. Regional blood flow to the brain was maintained under all experimental conditions, while the blood flow to the gastric fundal mucosa and to the pancreas significantly decreased following PEEP, oleic acid injection (OA) and with PEEP and oleic acid combination (P+OA). The renal blood flow decreased only during the P+OA phase. We conclude that the observed decrease in blood flow to the gastrointestinal mucosa and renal circulation in this acute low hydrostatic pressure pulmonary edema may correlate with the increased incidence of gastrointestinal and renal complications that accompany critically ill patients.

本研究的目的是探讨呼气末正压(PEEP=P)对犬低静液肺水肿模型中央和局部循环的影响。对8只油酸致肺水肿的杂种狗进行了有PEEP和无PEEP的人工通气。用放射性微球直接注射到左心室来测定局部血流量。在所有实验条件下,脑组织的局部血流量保持不变,而PEEP、油酸注射(OA)和PEEP与油酸联合(P+OA)后胃底黏膜和胰腺的血流量明显减少。肾血流量仅在P+OA期减少。我们的结论是,在这种急性低静水压力肺水肿中观察到的胃肠道粘膜和肾循环血流量的减少可能与危重患者胃肠道和肾脏并发症发生率的增加有关。
{"title":"Effects of oleic acid lung injury and positive end-expiratory pressure on central hemodynamics and regional blood flow.","authors":"S Walfisch,&nbsp;N Weksler,&nbsp;A Fisher,&nbsp;Y Shapira","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The objective of our study was to investigate the influence on central and regional circulation of the application of positive end-expiratory pressure (PEEP=P) in a canine model of low hydrostatic pulmonary edema. Eight mongrel dogs with oleic acid-induced pulmonary edema were artificially ventilated with and without PEEP. Regional blood flow was determined using radioactive microspheres directly injected into the left ventricle. Regional blood flow to the brain was maintained under all experimental conditions, while the blood flow to the gastric fundal mucosa and to the pancreas significantly decreased following PEEP, oleic acid injection (OA) and with PEEP and oleic acid combination (P+OA). The renal blood flow decreased only during the P+OA phase. We conclude that the observed decrease in blood flow to the gastrointestinal mucosa and renal circulation in this acute low hydrostatic pressure pulmonary edema may correlate with the increased incidence of gastrointestinal and renal complications that accompany critically ill patients.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"14-7"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis C virus genotypes in patients with persistent infection--a preliminary report. 持续感染患者的丙型肝炎病毒基因型——初步报告
Pub Date : 1997-01-01
V Bogomolski-Yahalom, Y Ashur, A Klein, R Tur-Kaspa

Hepatitis C virus (HCV) has nucleotide sequence diversity distributed throughout the viral genome, with variants showing even less than 70% homology. There is some evidence that sequence variation of HCV genotypes partly determines the course of infection and response to treatment with interferon. We studied the sera of 29 Israeli HCV patients, all suffering from chronic liver disease, and 34 patients with renal failure necessitating hemodialysis. HCV genotypes were detected using a reverse hybridization assay (LiPA), after reverse transcription polymerase chain reaction, using primers spanning the 5' UTR of the HCV genome. In this preliminary report the predominant HCV type detected was type 1, found in 65% of the chronic hepatitis patients and in 88% of the hemodialysis patients. Subtype 1b was the most prevalent and was detected in >40% of the chronic hepatitis patients and in >70%of the dialysis patients. Other types detected were 2a and 3, and in only two patients was type 4 found. More than 50% of patients with type 1 (1a or 1b) among patients with chronic hepatitis had received blood transfusion in the past, but only 16.6% of patients bearing subtype 2a HCV had such a history. Our preliminary evaluation revealed that patients bearing subtype 1b seemed to have a better response to interferon treatment, as compared with patients infected with subtypes 1a, 2a, who displayed a low response rate.

丙型肝炎病毒(HCV)在整个病毒基因组中具有核苷酸序列多样性,变异的同源性甚至低于70%。有证据表明,HCV基因型的序列变异在一定程度上决定了感染过程和对干扰素治疗的反应。我们研究了29名以色列HCV患者的血清,所有患者均患有慢性肝病,以及34名肾功能衰竭需要血液透析的患者。在逆转录聚合酶链反应后,使用跨越HCV基因组5' UTR的引物,使用反向杂交试验(LiPA)检测HCV基因型。在这份初步报告中,检测到的主要HCV类型为1型,在65%的慢性肝炎患者和88%的血液透析患者中发现。乙型肝炎亚型最常见,在>40%的慢性肝炎患者和>70%的透析患者中检出。其他检测到的类型是2a型和3型,只有2例患者发现了4型。在慢性肝炎患者中,超过50%的1型(1a或1b)患者过去曾接受过输血,但在2a亚型HCV患者中,只有16.6%的患者有输血史。我们的初步评估显示,与感染1a、2a亚型的患者相比,携带1b亚型的患者似乎对干扰素治疗有更好的反应,而1a、2a亚型的患者表现出较低的反应率。
{"title":"Hepatitis C virus genotypes in patients with persistent infection--a preliminary report.","authors":"V Bogomolski-Yahalom,&nbsp;Y Ashur,&nbsp;A Klein,&nbsp;R Tur-Kaspa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hepatitis C virus (HCV) has nucleotide sequence diversity distributed throughout the viral genome, with variants showing even less than 70% homology. There is some evidence that sequence variation of HCV genotypes partly determines the course of infection and response to treatment with interferon. We studied the sera of 29 Israeli HCV patients, all suffering from chronic liver disease, and 34 patients with renal failure necessitating hemodialysis. HCV genotypes were detected using a reverse hybridization assay (LiPA), after reverse transcription polymerase chain reaction, using primers spanning the 5' UTR of the HCV genome. In this preliminary report the predominant HCV type detected was type 1, found in 65% of the chronic hepatitis patients and in 88% of the hemodialysis patients. Subtype 1b was the most prevalent and was detected in >40% of the chronic hepatitis patients and in >70%of the dialysis patients. Other types detected were 2a and 3, and in only two patients was type 4 found. More than 50% of patients with type 1 (1a or 1b) among patients with chronic hepatitis had received blood transfusion in the past, but only 16.6% of patients bearing subtype 2a HCV had such a history. Our preliminary evaluation revealed that patients bearing subtype 1b seemed to have a better response to interferon treatment, as compared with patients infected with subtypes 1a, 2a, who displayed a low response rate.</p>","PeriodicalId":14590,"journal":{"name":"Israel journal of medical sciences","volume":"33 1","pages":"18-22"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20149043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Israel journal of medical sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1